Zymeworks ZYME
NASDAQ ZYME
$29.95 -1.50 (-4.78%)
As of: Nov 11, 2026 · 11:39 AM EST

Zymeworks (ZYME) Shares Repurchased (2024 - 2026)

Updated

Analysis

Zymeworks (ZYME) Shares Repurchased (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.71 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 653.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 370.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Zymeworks 2.24 Bn 1.27 Bn - 11.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 11.99 Mn
Jun 30, 2026 51.95 Mn
Mar 31, 2026 76.15 Mn
Dec 31, 2025 25.48 Mn
Sep 30, 2025 16.22 Mn
Dec 31, 2024 9.43 Mn
API Access

Zymeworks Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=ZYME&period=max&api_key=YOUR_API_KEY